| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/06/2011 | CN102000127A Preparation method of chimonanthus inhibited acetylcholinesterase active part and application thereof |
| 04/06/2011 | CN102000125A Ginkgo flavone extraction method |
| 04/06/2011 | CN102000121A Cordyceps militaris oligopeptide composition as well as preparation method and use thereof |
| 04/06/2011 | CN102000104A Use of triphosadenine and derivative thereof in preparation of antidepressant and/or antianxietic medicaments |
| 04/06/2011 | CN102000101A Application of scutellarin to treatment of microglia-mediated diseases |
| 04/06/2011 | CN102000096A Medicinal composition for treating Parkinson disease |
| 04/06/2011 | CN102000082A Medicament or health care food with memory strengthening effect |
| 04/06/2011 | CN102000074A Application of tetrahydroberberrubine in preparation of medicines for curing schizophrenia |
| 04/06/2011 | CN102000069A Mesembrianthemum-containing alkaloid and pharmaceutical compositions of related compounds |
| 04/06/2011 | CN102000049A Injection preparation containing etidocaine isomer |
| 04/06/2011 | CN102000039A Stable iloperidone capsule medicament composite |
| 04/06/2011 | CN102000037A Sublingual naloxone hydrochloride dripping pill |
| 04/06/2011 | CN101757570B Traditional Chinese medicine composition for treating cerebellar atrophy and preparation method thereof |
| 04/06/2011 | CN101757568B Traditional Chinese medicine composition for treating insomnia and preparation method thereof |
| 04/06/2011 | CN101700398B Traditional Chinese medicine decoction for antialcoholism |
| 04/06/2011 | CN101664452B Drug combination containing musk |
| 04/06/2011 | CN101627988B Application of structure modified products of salvianolic acid B in pharmacy |
| 04/06/2011 | CN101596260B Chinese patent medicine for treating epilepsy and postpartum epilepsy and preparation method thereof |
| 04/06/2011 | CN101590217B Chinese medicinal composition for treating dysthymia and preparation method thereof |
| 04/06/2011 | CN101536854B Health-caring process quilt |
| 04/06/2011 | CN101502592B Medicament for treating neurasthenia |
| 04/06/2011 | CN101474267B Medicament for treating psychasthenia, insomnia, vexation, encephalatrophy and dementia |
| 04/06/2011 | CN101468000B Application of bulleyaconitine A in preparing medicament for treating primary erythermalgia |
| 04/06/2011 | CN101406578B Plaster for curing facial paralysis |
| 04/06/2011 | CN101396456B Traditional Chinese medicine for treating peripheral nerve lesion of diabetes |
| 04/06/2011 | CN101317676B Puffed food made of sacred lotus husk |
| 04/06/2011 | CN101301283B Composition transferred through nose and brain containing milnacipran |
| 04/06/2011 | CN101288679B Dissolving and reducing generation method of nano pearl powder |
| 04/06/2011 | CN101198328B Solid pharmaceutical preparation containing (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 04/06/2011 | CN101167873B Technology for processing honey-prepared glutinous rehmannia |
| 04/06/2011 | CN101077373B Preparation for treating hepatic encephalopathy and preparation method thereof |
| 04/06/2011 | CN101031548B Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy) phenylmethyl) carbamide and their preparation |
| 04/05/2011 | US7919588 Netrin receptors |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919474 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2476350C Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 04/05/2011 | CA2461703C Modulation of physiological processes and agents useful for same |
| 04/05/2011 | CA2439274C Carbamate compounds for use in the treatment of pain |
| 04/05/2011 | CA2436402C Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 04/05/2011 | CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 04/05/2011 | CA2360326C Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 03/31/2011 | WO2011038152A2 Toll-like receptor modulators and uses thereof |
| 03/31/2011 | WO2011038124A2 Systems and methods for treating depression, including the use of neurobehavioral tasks |
| 03/31/2011 | WO2011038104A2 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
| 03/31/2011 | WO2011037833A2 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011037099A1 Composition comprising curcuma longa extract together with curcuma zedoaria extract |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036889A1 Heterocyclic compound |
| 03/31/2011 | WO2011036885A1 Heterocyclic compound |
| 03/31/2011 | WO2011036786A1 Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient |
| 03/31/2011 | WO2011036651A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011036297A2 Method for the therapy and diagnosis of alzheimer's disease |
| 03/31/2011 | WO2011036167A1 Use of nicotinic acetylcholine receptor alpha 7 activators |
| 03/31/2011 | WO2011035734A1 Relinqing extract, preparative method and use thereof |
| 03/31/2011 | WO2011017299A3 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
| 03/31/2011 | WO2011015646A3 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 03/31/2011 | WO2011012659A3 Diethyl 4-(4-fluorobenzylamino)-1,2-phenylenedicarbamate, and salts thereof |
| 03/31/2011 | WO2011004195A3 Cyclic triazo sodium channel blockers |
| 03/31/2011 | WO2010149658A3 Pharmaceutical composition comprising gamma - butyrobetaine and meldonium |
| 03/31/2011 | WO2010135610A3 Cell therapy for brain tissue damage |
| 03/31/2011 | WO2010132882A3 Sublingual dexmedetomidine compositions and methods of use thereof |
| 03/31/2011 | WO2010128807A3 Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases |
| 03/31/2011 | WO2010127143A3 Neuroprotective ganoderma compositions and methods of use |
| 03/31/2011 | WO2010124873A8 3- (2, 2, 2, trimethylhydrazinium) propionate dihydrate (meldonium) for treating parkinson' s disease |
| 03/31/2011 | WO2010118405A3 Compositions and methods for reducing hangover symptoms |
| 03/31/2011 | WO2010116141A3 Drug combination for the treatment of proteostatic diseases |
| 03/31/2011 | WO2010115050A3 Embryonic stem cell specific micrornas promote induced pluripotency |
| 03/31/2011 | WO2010106127A3 Method for therapeutic use |
| 03/31/2011 | WO2010088414A3 Subunit selective nmda receptor potentiators for the treatment of neurological conditions |
| 03/31/2011 | WO2010088408A3 Subunit selective nmda receptor antagonists for the treatment of neurological conditions |
| 03/31/2011 | WO2010085749A3 Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability |
| 03/31/2011 | WO2010083328A3 Methods for screening and compounds that protect against amyloid diseases |
| 03/31/2011 | WO2010069331A3 Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders |
| 03/31/2011 | WO2010066629A3 Novel azaindoles |
| 03/31/2011 | WO2010004256A8 Controlled release treatment of depression |
| 03/31/2011 | WO2009077858A3 Hemioxalate salt of eletriptan |
| 03/31/2011 | US20110078804 Angiogenin and Amyotrophic Lateral Sclerosis |
| 03/31/2011 | US20110077304 1-aminocyclohexane derivatives for the treatment of cochlear tinnitus. |
| 03/31/2011 | US20110077301 Novel methods of administering a mixture of fatty acids for the treatment of non-human mammals |
| 03/31/2011 | US20110077293 GAMBOGIC AMINE, A SELECTIVE TrkA AGONIST WITH NEUROPROTECTIVE ACTIVITY |
| 03/31/2011 | US20110077287 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions |
| 03/31/2011 | US20110077283 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 03/31/2011 | US20110077281 Formulations Comprising Triptain Compounds |
| 03/31/2011 | US20110077276 Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments |
| 03/31/2011 | US20110077274 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 03/31/2011 | US20110077272 Pulmonary formulations of triptans |
| 03/31/2011 | US20110077271 Process for the Preparation of Donepezil Hydrochloride |
| 03/31/2011 | US20110077269 Derivatives for modulation of ion channels |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077264 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 03/31/2011 | US20110077257 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof |
| 03/31/2011 | US20110077253 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 03/31/2011 | US20110077252 Pyridyl derivatives, their preparation and use |